Collegium Pharmaceutical Inc (COLL)

29.70 -0.74 (-2.43%) USD  |  NASDAQ  |  Dec 20, 16:00
30.80 +1.10 (+3.70%) After-Hours: 07:11
More

Collegium Pharmaceutical Max Drawdown (5Y): 52.45% for Nov. 30, 2024

Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for COLL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Max Drawdown (5Y) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Max Drawdown Definition

View Max Drawdown Definition
Start Trial

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Amicus Therapeutics Inc 74.97%
Insmed Inc 63.30%
Pulmonx Corp --
RxSight Inc --
PROCEPT BioRobotics Corp --

Max Drawdown (5Y) Related Metrics

Alpha (5Y) -6.046
Beta (5Y) 0.7976
Annualized Standard Deviation of Monthly Returns (5Y Lookback) 40.99%
Historical Sharpe Ratio (5Y) 0.1124
Historical Sortino (5Y) 0.1839
Monthly Value at Risk (VaR) 5% (5Y Lookback) 17.70%